Dhanuka Wasalathanthri, Ph.D.
About Dhanuka Wasalathanthri, Ph.D.
Dhanuka Wasalathanthri, Ph.D., is a Senior Scientist II at Bristol-Myers Squibb in New Jersey and a Scientist at Sanofi in France, with over 8 years of experience in the biotech industry.
Current Positions
Dhanuka Wasalathanthri, Ph.D., currently holds two significant roles in the pharmaceutical industry. He is a Senior Scientist II at Bristol-Myers Squibb in New Jersey, United States, a role he has been engaged in since October 2020. Additionally, he is employed as a Scientist at Sanofi in Aquitaine, France. These positions highlight his expertise in bio-process analytics and his commitment to advancing healthcare solutions.
Previous Experience
Before his current roles, Dhanuka Wasalathanthri contributed to various organizations in the biotech and academic sectors. He served as an Analytical Development Chemist at Biodel Inc. in Danbury, Connecticut, from 2014 to 2016. His academic career includes working as a Teaching Assistant at the University of Connecticut from 2009 to 2010, and as a Research Assistant at the same institution from 2009 to 2014. These roles provided him with a solid foundation in analytical and research methodologies.
Education and Expertise
Dhanuka Wasalathanthri achieved his Doctor of Philosophy (Ph.D.) in Chemistry from the University of Connecticut, where he studied from 2009 to 2014. His educational background and extensive research experience have equipped him with specialized skills in developing and validating multi-attribute chromatography-based online sensors. He also has significant expertise in bio-process analytics, particularly in late-stage commercial development, and extensive experience with microfluidic sensors.
Professional Background
With over 8 years of experience in the biotech industry, Dhanuka Wasalathanthri has developed a robust professional background. His work focuses primarily on analytical development and bio-process analytics in late-stage commercial development. His roles at Bristol-Myers Squibb and Sanofi, alongside his previous experiences at Biodel Inc. and the University of Connecticut, illustrate his extensive knowledge and practical skills in advancing pharmaceutical research and development.